Skip to main content
Top
Published in:

Open Access 19-11-2024 | Septicemia | Original Research Article

Health Economic Evaluation of Antimicrobial Stewardship, Procalcitonin Testing, and Rapid Blood Culture Identification in Sepsis Care: A 90-Day Model-Based, Cost-Utility Analysis

Authors: Wendy I. Sligl, Charles Yan, Jeff Round, Xiaoming Wang, Justin Z. Chen, Cheyanne Boehm, Karen Fong, Katelynn Crick, Míriam Garrido Clua, Cassidy Codan, Tanis C. Dingle, Connie Prosser, Guanmin Chen, Alena Tse-Chang, Daniel Garros, David Zygun, Dawn Opgenorth, John M. Conly, Christopher J. Doig, Vincent I. Lau, Sean M. Bagshaw

Published in: PharmacoEconomics - Open | Issue 1/2025

Login to get access

Abstract

Objective

We evaluated the cost-effectiveness of a bundled intervention including an antimicrobial stewardship program (ASP), procalcitonin (PCT) testing, and rapid blood culture identification (BCID), compared with pre-implementation standard care in critically ill adult patients with sepsis.

Methods

We conducted a decision tree model-based cost-effectiveness analysis alongside a previously published pre- and post-implementation quality improvement study. We adopted a public Canadian healthcare payer’s perspective. Two intensive care units in Alberta with 727 adult critically ill patients were included. Our bundled intervention was compared with pre-implementation standard care. We collected healthcare resource use and estimated unit costs in 2022 Canadian dollars (CAD) over a time horizon from study entry to hospital discharge or death. We calculated the incremental net monetary benefit (iNMB) of the intervention group compared with the pre-intervention group. The primary outcome was cost per sepsis case. Secondary outcomes included readmission rates, Clostridioides difficile infections, mortality, and lengths of stay. Uncertainty was investigated using cost-effectiveness acceptability curves, cost-effectiveness plane scatterplots, and sensitivity analyses.

Results

Mean (standard deviation [SD]) cost per index hospital admission was CAD $83,251 ($107,926) for patients in the intervention group and CAD $87,044 ($104,406) for the pre-intervention group, though the difference ($3,793 [$7,897]) was not statistically significant. Costs were higher in the pre-intervention group for antibiotics, readmissions, and C. difficile infections. The intervention group had a lower mean expected cost; $110,580 ($108,917) compared with pre-intervention ($125,745 [$113,210]), with a difference of $15,165 ($8278). There were no statistically significant differences in quality adjusted life years (QALYs) between groups. The iNMB of the intervention group compared with pre-intervention was greater than $15,000 for willingness-to-pay (WTP) per QALY values of between $0 and $100,000. In our sensitivity analysis, the intervention was most likely to be cost-effective in roughly 56% of simulations at all WTP thresholds.

Conclusions

Our bundled intervention of ASP, PCT, and BCID among adult critically ill patients with sepsis was potentially cost-effective, but with substantial decision uncertainty.
Appendix
Available only for authorised users
Literature
1.
go back to reference Vincent J-L, Marshall JC, Ñamendys-Silva SA, François B, Martin-Loeches I, Lipman J, et al. Assessment of the worldwide burden of critical illness: the intensive care over nations (ICON) audit. Lancet Respir Med. 2014;2(5):380–6.CrossRefPubMed Vincent J-L, Marshall JC, Ñamendys-Silva SA, François B, Martin-Loeches I, Lipman J, et al. Assessment of the worldwide burden of critical illness: the intensive care over nations (ICON) audit. Lancet Respir Med. 2014;2(5):380–6.CrossRefPubMed
2.
go back to reference Alberti C, Brun-Buisson C, Burchardi H, Martin C, Goodman S, Artigas A, et al. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med. 2002;28:108–21.CrossRefPubMed Alberti C, Brun-Buisson C, Burchardi H, Martin C, Goodman S, Artigas A, et al. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med. 2002;28:108–21.CrossRefPubMed
3.
go back to reference Paoli CJ, Reynolds MA, Sinha M, Gitlin M, Crouser E. Epidemiology and costs of sepsis in the United States—an analysis based on timing of diagnosis and severity level. Crit Care Med. 2018;46(12):1889.CrossRefPubMedPubMedCentral Paoli CJ, Reynolds MA, Sinha M, Gitlin M, Crouser E. Epidemiology and costs of sepsis in the United States—an analysis based on timing of diagnosis and severity level. Crit Care Med. 2018;46(12):1889.CrossRefPubMedPubMedCentral
4.
go back to reference Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181–247.CrossRefPubMedPubMedCentral Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181–247.CrossRefPubMedPubMedCentral
5.
go back to reference Vincent J-L, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302(21):2323–9.CrossRefPubMed Vincent J-L, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302(21):2323–9.CrossRefPubMed
6.
go back to reference Dellit TH, Owens RC, McGowan JE, Gerding DN, Weinstein RA, Burke JP, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44(2):159–77.CrossRefPubMed Dellit TH, Owens RC, McGowan JE, Gerding DN, Weinstein RA, Burke JP, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44(2):159–77.CrossRefPubMed
7.
go back to reference Luyt C-E, Bréchot N, Trouillet J-L, Chastre J. Antibiotic stewardship in the intensive care unit. Crit Care. 2014;18:1–12.CrossRef Luyt C-E, Bréchot N, Trouillet J-L, Chastre J. Antibiotic stewardship in the intensive care unit. Crit Care. 2014;18:1–12.CrossRef
8.
go back to reference Marston HD, Dixon DM, Knisely JM, Palmore TN, Fauci AS. Antimicrobial resistance. JAMA. 2016;316(11):1193–204.CrossRefPubMed Marston HD, Dixon DM, Knisely JM, Palmore TN, Fauci AS. Antimicrobial resistance. JAMA. 2016;316(11):1193–204.CrossRefPubMed
10.
go back to reference Pollack LA, Srinivasan A. Core elements of hospital antibiotic stewardship programs from the Centers for Disease Control and Prevention. Clin Infect Dis. 2014;59(suppl_3):S97–100.CrossRefPubMed Pollack LA, Srinivasan A. Core elements of hospital antibiotic stewardship programs from the Centers for Disease Control and Prevention. Clin Infect Dis. 2014;59(suppl_3):S97–100.CrossRefPubMed
11.
go back to reference Majumder MAA, Rahman S, Cohall D, Bharatha A, Singh K, Haque M, et al. Antimicrobial stewardship: fighting antimicrobial resistance and protecting global public health. Infect Drug Resist. 2020;13:4713–38.CrossRefPubMedPubMedCentral Majumder MAA, Rahman S, Cohall D, Bharatha A, Singh K, Haque M, et al. Antimicrobial stewardship: fighting antimicrobial resistance and protecting global public health. Infect Drug Resist. 2020;13:4713–38.CrossRefPubMedPubMedCentral
12.
go back to reference Dik J-WH, Hendrix R, Poelman R, Niesters HG, Postma MJ, Sinha B, et al. Measuring the impact of antimicrobial stewardship programs. Expert Rev Anti-Infect Ther. 2016;14(6):569–75.CrossRefPubMed Dik J-WH, Hendrix R, Poelman R, Niesters HG, Postma MJ, Sinha B, et al. Measuring the impact of antimicrobial stewardship programs. Expert Rev Anti-Infect Ther. 2016;14(6):569–75.CrossRefPubMed
13.
go back to reference Sligl WI, Chen JZ, Wang X, Boehm C, Fong K, Crick K, et al. Antimicrobial stewardship, procalcitonin testing, and rapid blood-culture identification to optimize sepsis care in critically ill adult patients: a quality improvement initiative. Antimicrob Steward Healthc Epidemiol. 2023;3(1): e107.CrossRefPubMedPubMedCentral Sligl WI, Chen JZ, Wang X, Boehm C, Fong K, Crick K, et al. Antimicrobial stewardship, procalcitonin testing, and rapid blood-culture identification to optimize sepsis care in critically ill adult patients: a quality improvement initiative. Antimicrob Steward Healthc Epidemiol. 2023;3(1): e107.CrossRefPubMedPubMedCentral
14.
go back to reference Glussich A. Estimating costs of a hospital stay. Ottawa: Canadian Institute for Health Information; 2020. Glussich A. Estimating costs of a hospital stay. Ottawa: Canadian Institute for Health Information; 2020.
15.
go back to reference Alberta Go. Overview of Administrative Health Datasets. 2017. Alberta Go. Overview of Administrative Health Datasets. 2017.
16.
go back to reference Leal JR, Conly J, Weaver R, Wick J, Henderson EA, Manns B, et al. Attributable costs and length of stay of hospital-acquired Clostridioides difficile: a population-based matched cohort study in Alberta, Canada. Infect Control Hosp Epidemiol. 2019;40(10):1135–43.CrossRefPubMed Leal JR, Conly J, Weaver R, Wick J, Henderson EA, Manns B, et al. Attributable costs and length of stay of hospital-acquired Clostridioides difficile: a population-based matched cohort study in Alberta, Canada. Infect Control Hosp Epidemiol. 2019;40(10):1135–43.CrossRefPubMed
17.
go back to reference Brundin-Mather R, Soo A, Zuege DJ, Niven DJ, Fiest K, Doig CJ, et al. Secondary EMR data for quality improvement and research: a comparison of manual and electronic data collection from an integrated critical care electronic medical record system. J Crit Care. 2018;47:295–301.CrossRefPubMed Brundin-Mather R, Soo A, Zuege DJ, Niven DJ, Fiest K, Doig CJ, et al. Secondary EMR data for quality improvement and research: a comparison of manual and electronic data collection from an integrated critical care electronic medical record system. J Crit Care. 2018;47:295–301.CrossRefPubMed
18.
go back to reference Westwood MM, Ramaekers BB, Whiting PP, Tomini F, Joore M, Armstrong NN, et al. Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis. Health Technol Assess. 2015;19(96):3–236.CrossRef Westwood MM, Ramaekers BB, Whiting PP, Tomini F, Joore M, Armstrong NN, et al. Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis. Health Technol Assess. 2015;19(96):3–236.CrossRef
19.
go back to reference Claxton K. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. J Health Econ. 1999;18(3):341–64.CrossRefPubMed Claxton K. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. J Health Econ. 1999;18(3):341–64.CrossRefPubMed
20.
21.
go back to reference Elwood M. Critical appraisal of epidemiological studies and clinical trials. Oxford: Oxford University Press; 2017.CrossRef Elwood M. Critical appraisal of epidemiological studies and clinical trials. Oxford: Oxford University Press; 2017.CrossRef
22.
go back to reference R Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2022. R Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2022.
23.
go back to reference Ramsey SD, Willke RJ, Glick H, Reed SD, Augustovski F, Jonsson B, et al. Cost-effectiveness analysis alongside clinical trials II—an ISPOR Good Research Practices Task Force report. Value in Health. 2015;18(2):161–72.CrossRefPubMed Ramsey SD, Willke RJ, Glick H, Reed SD, Augustovski F, Jonsson B, et al. Cost-effectiveness analysis alongside clinical trials II—an ISPOR Good Research Practices Task Force report. Value in Health. 2015;18(2):161–72.CrossRefPubMed
24.
go back to reference Glick HA, Doshi JA, Sonnad SS, Polsky D. Economic evaluation in clinical trials. Oxford: OUP; 2014.CrossRef Glick HA, Doshi JA, Sonnad SS, Polsky D. Economic evaluation in clinical trials. Oxford: OUP; 2014.CrossRef
25.
go back to reference Briggs AH, Mooney CZ, Wonderling DE. Constructing confidence intervals for cost-effectiveness ratios: an evaluation of parametric and non-parametric techniques using Monte Carlo simulation. Stat Med. 1999;18(23):3245–62.CrossRefPubMed Briggs AH, Mooney CZ, Wonderling DE. Constructing confidence intervals for cost-effectiveness ratios: an evaluation of parametric and non-parametric techniques using Monte Carlo simulation. Stat Med. 1999;18(23):3245–62.CrossRefPubMed
26.
go back to reference Briggs AH. Handling uncertainty in cost-effectiveness models. Pharmacoeconomics. 2000;17:479–500.CrossRefPubMed Briggs AH. Handling uncertainty in cost-effectiveness models. Pharmacoeconomics. 2000;17:479–500.CrossRefPubMed
27.
go back to reference Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press; 2015. Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press; 2015.
28.
go back to reference Ibrahim NH, Maruan K, Khairy HAM, Hong YH, Dali AF, Neoh CF. Economic evaluations on antimicrobial stewardship programme: a systematic review. J Pharm Pharm Sci. 2017;20:397–406.CrossRefPubMed Ibrahim NH, Maruan K, Khairy HAM, Hong YH, Dali AF, Neoh CF. Economic evaluations on antimicrobial stewardship programme: a systematic review. J Pharm Pharm Sci. 2017;20:397–406.CrossRefPubMed
29.
go back to reference Scheetz MH, Bolon MK, Postelnick M, Noskin GA, Lee TA. Cost-effectiveness analysis of an antimicrobial stewardship team on bloodstream infections: a probabilistic analysis. J Antimicrob Chemother. 2009;63(4):816–25.CrossRefPubMed Scheetz MH, Bolon MK, Postelnick M, Noskin GA, Lee TA. Cost-effectiveness analysis of an antimicrobial stewardship team on bloodstream infections: a probabilistic analysis. J Antimicrob Chemother. 2009;63(4):816–25.CrossRefPubMed
30.
go back to reference Ruiz-Ramos J, Frasquet J, Roma E, Poveda-Andres JL, Salavert-Leti M, Castellanos A, et al. Cost-effectiveness analysis of implementing an antimicrobial stewardship program in critical care units. J Med Econ. 2017;20(6):652–9.CrossRefPubMed Ruiz-Ramos J, Frasquet J, Roma E, Poveda-Andres JL, Salavert-Leti M, Castellanos A, et al. Cost-effectiveness analysis of implementing an antimicrobial stewardship program in critical care units. J Med Econ. 2017;20(6):652–9.CrossRefPubMed
31.
go back to reference Dik J-WH, Hendrix R, Friedrich AW, Luttjeboer J, Nannan Panday P, Wilting KR, et al. Cost-minimization model of a multidisciplinary antibiotic stewardship team based on a successful implementation on a urology ward of an academic hospital. PLoS ONE. 2015;10(5):e0126106.CrossRefPubMedPubMedCentral Dik J-WH, Hendrix R, Friedrich AW, Luttjeboer J, Nannan Panday P, Wilting KR, et al. Cost-minimization model of a multidisciplinary antibiotic stewardship team based on a successful implementation on a urology ward of an academic hospital. PLoS ONE. 2015;10(5):e0126106.CrossRefPubMedPubMedCentral
32.
go back to reference Okumura LM, Riveros BS, Gomes-da-Silva MM, Veroneze I. A cost-effectiveness analysis of two different antimicrobial stewardship programs. Braz J Infect Dis. 2016;20:255–61.CrossRefPubMedPubMedCentral Okumura LM, Riveros BS, Gomes-da-Silva MM, Veroneze I. A cost-effectiveness analysis of two different antimicrobial stewardship programs. Braz J Infect Dis. 2016;20:255–61.CrossRefPubMedPubMedCentral
33.
go back to reference van Daalen FV, Opmeer BC, Prins JM, Geerlings SE, Hulscher MEL. The economic evaluation of an antibiotic checklist as antimicrobial stewardship intervention. J Antimicrob Chemother. 2017;72(11):3213–21.CrossRefPubMed van Daalen FV, Opmeer BC, Prins JM, Geerlings SE, Hulscher MEL. The economic evaluation of an antibiotic checklist as antimicrobial stewardship intervention. J Antimicrob Chemother. 2017;72(11):3213–21.CrossRefPubMed
35.
go back to reference Mponponsuo K, Leal J, Spackman E, Somayaji R, Gregson D, Rennert-May E. Mathematical model of the cost-effectiveness of the BioFire FilmArray Blood Culture Identification (BCID) Panel molecular rapid diagnostic test compared with conventional methods for identification of Escherichia coli bloodstream infections. J Antimicrob Chemother. 2022;77(2):507–16.CrossRefPubMed Mponponsuo K, Leal J, Spackman E, Somayaji R, Gregson D, Rennert-May E. Mathematical model of the cost-effectiveness of the BioFire FilmArray Blood Culture Identification (BCID) Panel molecular rapid diagnostic test compared with conventional methods for identification of Escherichia coli bloodstream infections. J Antimicrob Chemother. 2022;77(2):507–16.CrossRefPubMed
36.
go back to reference Axelrod DA, Hayward R. Nonrandomized interventional study designs (quasi-experimental designs). In: Clinical research methods for surgeons. Totowa: Springer; 2006. p. 63–76. Axelrod DA, Hayward R. Nonrandomized interventional study designs (quasi-experimental designs). In: Clinical research methods for surgeons. Totowa: Springer; 2006. p. 63–76.
37.
go back to reference Taggart LR, Leung E, Muller MP, Matukas LM, Daneman N. Differential outcome of an antimicrobial stewardship audit and feedback program in two intensive care units: a controlled interrupted time series study. BMC Infect Dis. 2015;15:480.CrossRefPubMedPubMedCentral Taggart LR, Leung E, Muller MP, Matukas LM, Daneman N. Differential outcome of an antimicrobial stewardship audit and feedback program in two intensive care units: a controlled interrupted time series study. BMC Infect Dis. 2015;15:480.CrossRefPubMedPubMedCentral
38.
go back to reference Lindsay PJ, Rohailla S, Taggart LR, et al. Antimicrobial stewardship and intensive care unit mortality: a systematic review. Clin Infect Dis. 2019;68:748–56.CrossRefPubMed Lindsay PJ, Rohailla S, Taggart LR, et al. Antimicrobial stewardship and intensive care unit mortality: a systematic review. Clin Infect Dis. 2019;68:748–56.CrossRefPubMed
39.
go back to reference Morris AM, Bai A, Burry L, et al. Long-term effects of phased implementation of antimicrobial stewardship in academic ICUs: 2007–2015. Crit Care Med. 2019;47:159–66.CrossRefPubMed Morris AM, Bai A, Burry L, et al. Long-term effects of phased implementation of antimicrobial stewardship in academic ICUs: 2007–2015. Crit Care Med. 2019;47:159–66.CrossRefPubMed
Metadata
Title
Health Economic Evaluation of Antimicrobial Stewardship, Procalcitonin Testing, and Rapid Blood Culture Identification in Sepsis Care: A 90-Day Model-Based, Cost-Utility Analysis
Authors
Wendy I. Sligl
Charles Yan
Jeff Round
Xiaoming Wang
Justin Z. Chen
Cheyanne Boehm
Karen Fong
Katelynn Crick
Míriam Garrido Clua
Cassidy Codan
Tanis C. Dingle
Connie Prosser
Guanmin Chen
Alena Tse-Chang
Daniel Garros
David Zygun
Dawn Opgenorth
John M. Conly
Christopher J. Doig
Vincent I. Lau
Sean M. Bagshaw
Publication date
19-11-2024
Publisher
Springer International Publishing
Published in
PharmacoEconomics - Open / Issue 1/2025
Print ISSN: 2509-4262
Electronic ISSN: 2509-4254
DOI
https://doi.org/10.1007/s41669-024-00538-y